Pharmacy groups unite to laud bipartisan Congressional focus on closing the loophole that inflates drug costs for patients and Medicare, and jeopardizes pharmacies.
Bipartisan support is strong for a legislative fix to the loophole that inflates drug costs for patients and for Medicare, and that jeopardizes pharmacies.
DIR fee relief is motivating a record-breaking NACDS RxIMPACT Congressional letter-writing campaign. The effort to end the abuse of DIR fees includes three focuses right now. Learn more.
NACDS emphasized the need for Congress to address direct and indirect remuneration (DIR) fee relief as it considers solutions to reduce healthcare costs.
NACDS RxIMPACT's largest grassroots initiative ever has led to pharmacy advocates sending more than 4,700 letters to Congress--to date--urging DIR reform.
This week, the Harmons Neighborhood Grocery pharmacy in Riverton, Utah, hosted their member of Congress, Representative Ben McAdams.
Grassroots engagement supporting Phair Pricing Act is crucial for pharmacy viability and to reduce seniors' out-of-pocket drug costs.
NCPA and NACDS: "We are disappointed and frustrated that this final rule fails to finalize pharmacy DIR reform as proposed, to the detriment of seniors and community pharmacies. Our organizations have been joined by many pharmacists, pharmacy stakeholder groups, patient advocacy organizations, patients, and members of Congress in advocating that all pharmacy price concessions be included at the point of sale – or eliminated altogether – to provide senior patients with lower costs and pharmacies with more certainty..."
NACDS recommended several measures to lower prescription drug prices and improve patient health--including DIR fee relief--to the House Committee on Energy and Commerce Subcommittee on Health.
Medium post urges action on DIR fee relief in final Medicare rule.
